Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Lindenauer, Peter
Cost-Utility Analysis of 1- and 2-Level Dorsal Lumbar Fusions With and Without Recombinant Human Bone Morphogenic Protein-2 at 1-Year Follow-Up.
Libraries, Digital
COUP Transcription Factor I
Measuring tumor mutation burden in cell-free DNA: advantages and limits.
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Measuring tumor mutation burden in cell-free DNA: advantages and limits.
Addeo A, Weiss GJ. Measuring tumor mutation burden in cell-free DNA: advantages and limits. Transl Lung Cancer Res. 2019 Aug; 8(4):553-555.
View in:
PubMed
authors with profiles
Glen Weiss MD, MBA